New research indicates that patients who discontinue blockbuster slimming jabs like Mounjaro or Wegovy can put back on lost weight much more quickly than those who end conventional diet and exercise programs.
Findings released in a leading health publication points out that while overweight individuals often shed substantial amounts of their total mass while using the jabs, the weight is regained at an average rate of 0.8 kg per month once they quit.
"Individuals using these drugs need to be aware of the danger of quick rebound weight gain when the medication is stopped," warns researcher Dr. Susan Jebb.
Such speed of recovery suggests a reversion to original mass in about 18 months.
Weighing Therapies
The research, which reviewed dozens of studies involving over 9,000 of patients, compared the effects of the injectable medications with other pills.
Researchers point out that individuals who lose weight through diet and exercise generally see a less rapid creep back—around 0.1 kg a month—once they finish.
The Reason for the Rapid Rebound
Nutrition scientists believe the mode of action of the injections is key to understanding the heightened regain.
The injections copy a body's own chemical called GLP-1, which helps regulate appetite.
"Long-term administration of the hormone concentrations several times higher than the body's typical production could lead to the system to produce less of its own natural GLP-1, and could reduce responsiveness to its effects," said Dr. Adam Collins, a dietetics expert.
"Discontinuation of this medication leads to hunger is unsuppressed, making excessive eating a significant risk."
A Lifelong Condition?
Health authorities suggest the injections for individuals with obesity-related medical conditions, alongside prescribed diet and exercise modifications.
A number of clinicians argue that, given the high risk of relapse, the treatment should be considered ongoing.
This opinion is echoed by pharmaceutical companies, who say that the findings "emphasize the chronic nature of excess weight," akin to managing diseases like high blood pressure.
Patient Accounts
Individuals who have come off the medication report a sudden return of appetite.
"It was like a switch flipping and you're instantly ravenous," said one woman.
This difficulty is compounded if patients have not established lasting lifestyle or habit changes during therapy.
Significant Use
Figures indicate that a significant number of people in the UK have tried weight-loss jabs in the last 12 months, with desire continuing to grow.
- Adoption is higher among women compared to males.
- The middle-aged age group shows the greatest usage rates.
- A large proportion obtain the medications through private prescriptions rather than public health services.
Ultimately, clinicians emphasize that while GLP-1 drugs are powerful agents for weight loss, they are not a permanent solution and long-term success likely depends on integrated behavioural management.